{"id":"W4383481487","doi":"10.1080/13696998.2023.2234235","title":"Cost-effectiveness of tezepelumab in Canada for severe asthma","year":2023,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada); University of Alberta; AstraZeneca (Canada)","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Asthma; Cost–utility analysis; Exacerbation; Quality-adjusted life year; Cost-effectiveness analysis; Cost effectiveness; Incremental cost-effectiveness ratio; Cohort; Cost–benefit analysis; Emergency medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002393931,0.0008299122,0.0008683135,0.001030692,0.0008735192,0.001733398,0.001289683,0.0008605206,0.003445603],"category_scores_gemma":[0.01154898,0.0003730701,0.002434974,0.001302706,0.0007151159,0.0006308029,0.0007442864,0.001253357,0.0001111229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07088895,"about_ca_system_score_gemma":0.07651933,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9518209,"about_ca_topic_score_gemma":0.9529323,"domain_scores_codex":[0.998265,0.0006683998,0.00007327229,0.0001551075,0.0005154547,0.0003228997],"domain_scores_gemma":[0.9974371,0.000962375,0.000399725,0.0000645702,0.000696214,0.0004400021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.03988265,0.001387493,0.1554084,0.00523878,0.008024162,0.000904735,0.0003524706,0.5066175,0.001963608,0.01554029,0.02138458,0.2432953],"study_design_scores_gemma":[0.01786047,0.007536696,0.2941273,0.003554294,0.01424455,0.001236758,0.00115164,0.6195384,0.002689759,0.01025389,0.02739441,0.0004118331],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9057109,0.03520052,0.005932562,0.0103706,0.0002450607,0.002130351,0.01741093,0.0001965227,0.02280238],"genre_scores_gemma":[0.9912565,0.003372515,0.00204381,0.0004341411,0.00001916133,0.0001349234,0.001751114,0.00001114774,0.0009767701],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07088895,"threshold_uncertainty_score":0.5143378,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03029584279058423,"score_gpt":0.3078310479287403,"score_spread":0.277535205138156,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}